Omeros up on reimbursement code for Omidria

Omeros (NASDAQ:OMER) is up on the heels of the establishment of a permanent U.S. reimbursement code for eye drop OMIDRIA (phenylephrine and ketorolac intraocular solution) 1% / 0.3%. The code will go into effect October 1.

https://seekingalpha.com/news/3480805-omeros-2-percent-premarket-reimbursement-code-omidria